4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
March 15, 2010 08:00 am US/Eastern
Search
Dynamic quotes   
On
 | Off

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI-AVENTIS   SAN   FR0000120578

Real time Streaming quotes -

SANOFI-AVENTIS (SAN)

  
Real-time Quote. Real-time Tradegate - 03/15 08:00:15 am
56.145 EUR   +1.34%
03:25 amSANOFI-AVENTIS: Filing of the 2009 U.S. Form 20-F and French ?Do..
03/11SANOFI-AVENTIS: Successfully Completes the Acquisition of Chatte..
03/09SANOFI-AVENTIS: and Merck to create a Global Leader in Animal He..
SummaryQuotesChart AnalysisNewsCompanyFundamentalsConsensus
 NewsRSS News
Latest news on SANOFI-AVENTIS
03:25 amFiling of the 2009 U.S. Form 20-F and French ?Document de Référence? a..
03/11Successfully Completes the Acquisition of Chattem, Inc.
03/09And Merck to create a Global Leader in Animal Health
03/04Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refr..
03/02Board of Directors of sanofi-aventis
02/26Information concerning the total number of voting rights and shares, p..
02/19Sanofi Pasteur's A(H1N1) Vaccine HUMENZA®* Recommended by European Med..
02/18Strengthens Commitment to Research in France through Partnership with ..
02/15My child matters Supports Seven New Childhood Cancer Care Projects
02/09Successfully Completes Tender Offer for Chattem, Inc.
01/29Signs Agreements to Establish New Consumer Healthcare Joint Venture in..
01/25Information concerning the total number of voting rights and shares, p..
01/21And employees unite for the victims of Haiti
01/08Reinforces its Consumer Health Care Management
2009FDA Licenses New Influenza Vaccine Designed Specifically for People 65..
2009Information concerning the total number of voting rights and shares, p..
2009To Acquire Chattem Inc.Creating a Strong U.S. Consumer Healthcare Plat..
2009Provides an R&D Pipeline update
2009Board of Directors of December 16, 2009
2009Sanofi Pasteur Obtains License from Syntiron to Develop & Commercializ..
2009Sanofi Pasteur expands study of vaccine against Clostridium difficile ..
2009BiPar Sciences Announces Update on the Clinical Development Progress o..
2009Doubles syringe production capacity and diversifies vaccine production..
2009And U.S Biotechnology company Alopexx enter into a collaboration agree..
2009Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Lati..
2009Establishes strategic research alliance with California Institute of T..
2009Enters into an Exclusive Global Licensing Agreement with The Rockefell..
2009Multaq® Approved in the European Union for Patients with Atrial Fibril..
2009Confirms its intent to reinforce its presence in the Russian Federatio..
2009Confirms its intent to reinforce its presence in the Russian Federatio..
2009And Medicines for Malaria Venture to launch the largest ever study of ..
2009Launches Major New Registry Including Over 10,000 patients Worldwide w..
2009Panenza®*, Sanofi Pasteur's Influenza A(H1N1) 2009 Vaccine, Approved i..
2009And Regeneron expand strategic Antibody Collaboration
2009Announces Changes to Executive Committee
2009And US Biopharmaceutical Company Micromet Sign Global Collaboration an..
2009And Wellstat Therapeutics enter into an Exclusive Worldwide Licensing ..
2009Information concerning the total number of voting rights and shares, p..
2009Merial invests US $ 70 million in Nanchang, China
2009Panenza®* and Humenza®* Influenza A(H1N1) Vaccines Demonstrate Robust ..
2009Sanofi Pasteur and the Alliance for Rabies Control enter into a Global..
2009And U.S. Biotechnology company Merrimack enter into an Exclusive Globa..
2009Superior efficacy-dose ratio for Lantus® over detemir
2009Announces Dismissal of U.S. Securities Law Suit regarding Zimulti® (ri..
2009Multaq® (dronedarone) Recommended for Approval in the European Union
2009Sanofi Pasteur Commends Results of First HIV Vaccine Study to Show Som..
2009Receives renewed recognition as a leader in sustainability
2009Completes Acquisition of Merck's Interest in Merial
2009Completes Acquisition of Merck's Interest in Merial
2009Receives Complete Response Letter from the FDA for Eplivanserin (Cilty..
1  2  3  4  5Next
Chart SANOFI-AVENTIS
Short term
Mid-term
Long term
Graphique historique des cours de bourse de SANOFI-AVENTIS
>> Full-screen chart
Price share SANOFI-AVENTIS (FRANCE), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /